Andrew J. Colebatch - Concepedia

Author

Andrew J. Colebatch

The University of Sydney ORCID

Also Known As

A Colebatch, A. Colebatch, A. J. Colebatch, A.J. Colebatch, Andrew Colebatch, Andrew J Colebatch, Andrew J. Colebatch

141

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

The University of Sydney Royal Prince Alfred Hospital Melanoma Institute Australia Royal North Shore Hospital Peter MacCallum Cancer Centre

About

Andrew J. Colebatch is an author at The University of Sydney specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	569
2	Cell Biology	2	2	64
3	Engineering	1	1	73
4	Health Sciences	1	1	16
5	Immunology	1	1	42

Andrew J. Colebatch

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial Irene L. M. Reijers, Alexander M. Menzies, Alexander C. J. van Akkooi, Nature Medicine Surgical OncologyOncologyPrado TrialMelanomaClinical Trials	2022	322
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas Stephen Q. Wong, Kelly Waldeck, Ismael A. Vergara, Cancer Research	2015	318
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma Heloise M. Halse, Andrew J. Colebatch, Pasquale Petrone, Scientific Reports	2018	124
Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population Julie Paik, Geoffrey Hall, Adele Clarkson, Human Pathology	2011	115
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma Stephen Q. Wong, Jeanette Raleigh, Jason Callahan, JCO Precision Oncology	2017	109
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes Felicity Newell, Peter A. Johansson, James S. Wilmott, Cancer Discovery	2022	97
Molecular Genomic Profiling of Melanocytic Nevi Andrew J. Colebatch, Peter M. Ferguson, Felicity Newell, Journal of Investigative Dermatology Functional GenomicsMolecular Genomic ProfilingEngineeringMedicineMelanoma	2019	73
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling Ismael A. Vergara, Christopher Mintoff, Shahneen Sandhu, Nature Communications	2021	73
The role of MYH and microsatellite instability in the development of sporadic colorectal cancer Andrew J. Colebatch, Megan P. Hitchins, Rachel Williams, British Journal of Cancer Somatic VariantTumor HeterogeneityMedicineGeneticsMicrosatellite Instability	2006	52
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy Grace H. Attrill, C. Owen, Tasnia Ahmed, Journal for ImmunoTherapy of Cancer	2022	48

Page 1